mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function

Autor: Peter Vogel, Caryn Cloer, Geoffrey Neale, Hongbo Chi, Hu Zeng, Kai Yang
Rok vydání: 2012
Předmět:
Interleukin 2
Population
Receptors
Antigen
T-Cell

Mevalonic Acid
chemical and pharmacologic phenomena
mTORC1
Biology
Mechanistic Target of Rapamycin Complex 1
T-Lymphocytes
Regulatory

Article
Immune tolerance
Inducible T-Cell Co-Stimulator Protein
03 medical and health sciences
Mice
0302 clinical medicine
Immune system
medicine
Immune Tolerance
Animals
CTLA-4 Antigen
Age of Onset
education
PI3K/AKT/mTOR pathway
030304 developmental biology
Adaptor Proteins
Signal Transducing

Cell Proliferation
Inflammation
0303 health sciences
education.field_of_study
Multidisciplinary
TOR Serine-Threonine Kinases
T-cell receptor
FOXP3
Proteins
hemic and immune systems
Forkhead Transcription Factors
Regulatory-Associated Protein of mTOR
Lipid Metabolism
Cell biology
Survival Rate
Cholesterol
Multiprotein Complexes
Interleukin-2
biological phenomena
cell phenomena
and immunity

Carrier Proteins
030215 immunology
medicine.drug
Signal Transduction
Zdroj: Nature
ISSN: 1476-4687
Popis: The mechanistic target of rapamycin (mTOR) pathway integrates diverse environmental inputs, including immune signals and metabolic cues, to direct T-cell fate decisions. The activation of mTOR, which is the catalytic subunit of the mTORC1 and mTORC2 complexes, delivers an obligatory signal for the proper activation and differentiation of effector CD4(+) T cells, whereas in the regulatory T-cell (T(reg)) compartment, the Akt-mTOR axis is widely acknowledged as a crucial negative regulator of T(reg)-cell de novo differentiation and population expansion. However, whether mTOR signalling affects the homeostasis and function of T(reg) cells remains largely unexplored. Here we show that mTORC1 signalling is a pivotal positive determinant of T(reg)-cell function in mice. T(reg) cells have elevated steady-state mTORC1 activity compared to naive T cells. Signals through the T-cell antigen receptor (TCR) and interleukin-2 (IL-2) provide major inputs for mTORC1 activation, which in turn programs the suppressive function of T(reg) cells. Disruption of mTORC1 through Treg-specific deletion of the essential component raptor leads to a profound loss of T(reg)-cell suppressive activity in vivo and the development of a fatal early onset inflammatory disorder. Mechanistically, raptor/mTORC1 signalling in T(reg) cells promotes cholesterol and lipid metabolism, with the mevalonate pathway particularly important for coordinating T(reg)-cell proliferation and upregulation of the suppressive molecules CTLA4 and ICOS to establish Treg-cell functional competency. By contrast, mTORC1 does not directly affect the expression of Foxp3 or anti- and pro-inflammatory cytokines in T(reg) cells, suggesting a non-conventional mechanism for T(reg)-cell functional regulation. Finally, we provide evidence that mTORC1 maintains T(reg)-cell function partly through inhibiting the mTORC2 pathway. Our results demonstrate that mTORC1 acts as a fundamental 'rheostat' in T(reg) cells to link immunological signals from TCR and IL-2 to lipogenic pathways and functional fitness, and highlight a central role of metabolic programming of T(reg)-cell suppressive activity in immune homeostasis and tolerance.
Databáze: OpenAIRE